SterRx Epinephrine Injection Recalled for Lack of Sterility Assurance
SterRx is recalling epinephrine in 0.9% sodium chloride injection (4 mg per 250 mL) nationwide due to lack of assurance of sterility. The recall affects 26,928 bags distributed across the United States.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall of a sterile injectable pharmaceutical product. Lack of assurance of sterility in injectable medications poses a serious risk of infection, contamination, and patient harm. Although no reported illnesses or injuries are stated in the source text, the compromised sterility of an injection product distributed nationwide warrants a Severe classification under FDA Class II criteria.
Plain-English summary
SterRx, LLC is recalling EPINEPHIrine in 0.9% Sodium Chloride Injection, 4 mg per 250 mL (16 mcg per mL), NDC 70324-227-01, due to lack of assurance of sterility. The product is an injectable prescription medication used for emergency treatment of severe allergic reactions and other acute conditions requiring epinephrine.
Approximately 26,928 bags have been distributed nationwide. Affected lots include S21254/BWZ (released 22-Nov-21), S21263/BXG (released 30-Nov-21), S21333/BZT (released 11-Jan-22), and S21398/CCG (released 19-Feb-22).
Consumers and healthcare providers in possession of this product should stop using it immediately and contact SterRx, LLC at 141 Idaho Ave., Plattsburgh, NY 12903 for return instructions or additional information. Because epinephrine is a life-saving emergency medication, patients who depend on this product should consult their healthcare provider about alternative supplies.
The recalled product
- Product
- EPINEPHIrine in 0.9% Sodium Chloride Injection, 4 mg per 250 mL (16 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-227-01.
- Manufacturer
- SterRx, LLC
- Category
- Drug — Injectable / Epinephrine
- Hazard
- sterility-assurance
- contamination-risk
- infection-risk
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27